nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.01.2009 | Original Article

Calculation of electron dose to target cells in a complex environment by Monte Carlo code “CELLDOSE”

verfasst von: Elif Hindié, Christophe Champion, Paolo Zanotti-Fregonara, Domenico Rubello, Nicole Colas-Linhart, Laura Ravasi, Jean-Luc Moretti

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

We used the Monte Carlo code “CELLDOSE” to assess the dose received by specific target cells from electron emissions in a complex environment. ¹³¹I in a simulated thyroid was used as a model.

Methods

Thyroid follicles were represented by 170 μm diameter spherical units made of a lumen of 150 μm diameter containing colloidal matter and a peripheral layer of 10 μm thick thyroid cells. Neighbouring follicles are 4 μm apart. ¹³¹I was assumed to be homogeneously distributed in the lumen and absent in cells. We firstly assessed electron dose distribution in a single follicle. Then, we expanded the simulation by progressively adding neighbouring layers of follicles, so to reassess the electron dose to this single follicle implemented with the contribution of the added layers.

Results

Electron dose gradient around a point source showed that the ¹³¹I electron dose is close to zero after 2,100 μm. Therefore, we studied all contributions to the central follicle deriving from follicles within 12 orders of neighbourhood (15,624 follicles surrounding the central follicle). The dose to colloid of the single follicle was twice as high as the dose to thyroid cells. Even when all neighbours were taken into account, the dose in the central follicle remained heterogeneous. For a 1-Gy average dose to tissue, the dose to colloidal matter was 1.168 Gy, the dose to thyroid cells was 0.982 Gy, and the dose to the inter-follicular tissue was 0.895 Gy. Analysis of the different contributions to thyroid cell dose showed that 17.3% of the dose derived from the colloidal matter of their own follicle, while the remaining 82.7% was delivered by the surrounding follicles. On the basis of these data, it is shown that when different follicles contain different concentrations of ¹³¹I, the impact in terms of cell dose heterogeneity can be important.

Conclusion

By means of ¹³¹I in the thyroid as a theoretical model, we showed how a Monte Carlo code can be used to map electron dose deposit and build up the dose to target cells in a complex multi-source environment. This approach can be of considerable interest for comparing different radiopharmaceuticals as therapy agents in oncology.

Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 1999;40:37S–61S.PubMed

Kassis AI. Radiobiologic principles in radionuclide therapy. J Nucl Med 2005;46(Suppl 1):4S–12S. Review.PubMed

Neti PV, Howell RW. Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells. J Nucl Med 2004;45:1050–8.PubMed

Hindorf C, Emfietzoglou D, Lindén O, Bousis C, Fotopoulos A, Kostarelos K, et al. Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread. Cancer Biother Radiopharm 2007;22:357–66.PubMedCrossRef

Cariati M, Purushotham AD. Stem cells and breast cancer. Histopathology 2008;52:99–107. Review.PubMed

Ricci-Vitiani L, Pagliuca A, Palio E, Zeuner A, De Maria R. Colon cancer stem cells. Gut 2008;57:538–48. Review.PubMedCrossRef

Goddu SM, Howell RW, Rao DV. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med 1994;35:303–16.PubMed

Goddu SM, Rao DV, Howell RW. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J Nucl Med 1994;35:521–30.PubMed

Hartman T, Lundqvist H, Westlin JE, Carlsson J. Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies. Int J Radiat Oncol Biol Phys 2000;46:1025–36.PubMed

10.

Champion C, Zanotti-Fregonara P, Hindié E. CELLDOSE: a Monte Carlo code to assess electron dose distribution—S values for 131-I in spheres of various sizes. J Nucl Med 2008;49:151–7.PubMedCrossRef

11.

Bardies M, Chatal JF. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres. Phys Med Biol 1994;39:961–81.PubMedCrossRef

12.

Li WB, Friedland W, Pomplun E, Jacob P, Paretzke HG, Lassmann M, et al. Track structures and dose distributions from decays of (131)I and (125)I in and around water spheres simulating micrometastases of differentiated thyroid cancer. Radiat Res 2001;156:419–29.PubMedCrossRef

13.

Dunn JT, Dunn AD. Update on intrathyroidal iodine metabolism. Thyroid 2001;11:407–14. Review.PubMedCrossRef

14.

Zanzonico PB. Age-dependent thyroid absorbed doses for radiobiologically significant radioisotopes of iodine. Health Phys 2000;78:60–7.PubMed

15.

Lowenstein JE, Wollman SH. Distribution of organic 125-I and 127-I in the rat thyroid gland during equilibrium labeling as determined by autoradiography. Endocrinology 1967;81:1074–85.PubMedCrossRef

16.

Hindie E, Petiet A, Bourahla K, Colas-Linhart N, Slodzian G, Dennebouy R, et al. Microscopic distribution of iodine radioisotopes in the thyroid of the iodine deficient new-born rat: insight concerning the Chernobyl accident. Cell Mol Biol (Noisy-le-grand) 2001;47:403–10.

17.

Wilson JD, Foster DW. Williams textbook of endocrinology. 8th ed. Philadelphia: Saunders; 1992.

18.

Champion C. Theoretical cross sections for electron collisions in water: structure of electron tracks. Phys Med Biol 2003;48(14):2147–68. Jul 21.PubMedCrossRef

19.

Cross WG, Freedman NO, Wong PY. Beta-ray dose distributions from point sources in an infinite water medium. Health Phys 1992;63:160–71.PubMed

20.

Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, et al. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions—radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med 1999;40:11S–36S.PubMed

21.

ICRU Report 67. Absorbed-dose specification in nuclear medicine. By ICRU, p. 110, 2002. Nuclear Technology, Ashford, UK.

22.

Sgouros G. Dosimetry of internal emitters. J Nucl Med 2005;46(Suppl 1):18S–27S. Jan, Review.PubMed

23.

Barthe N, Chatti K, Coulon P, Maîtrejean S, Basse-Cathalinat B. Recent technologic developments on high-resolution beta imaging systems for quantitative autoradiography and double labeling applications. Nucl Instrum Methods Phys Res A 2004;527:41–5.CrossRef

24.

Puncher MR, Blower PJ. Radionuclide targeting and dosimetry at the microscopic level: the role of microautoradiography. Eur J Nucl Med 1994;21:1347–65. Review.PubMedCrossRef

25.

Stumpf WE. Drug localization and targeting with receptor microscopic autoradiography. J Pharmacol Toxicol Methods 2005;51:25–40.PubMedCrossRef

26.

Chehade F, de Labriolle-Vaylet C, Moins N, Moreau MF, Papon J, Labarre P, et al. Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA. J Nucl Med 2005;46:1701–6.PubMed

27.

Lechene C, Hillion F, McMahon G, Benson D, Kleinfeld AM, Kampf JP, et al. High-resolution quantitative imaging of mammalian and bacterial cells using stable isotope mass spectrometry. J Biol 2006;5(6):20.PubMedCrossRef

28.

Prestwich WV, Nunes J, Kwok CS. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. J Nucl Med 1989;30:1036–46. Erratum in: J Nucl Med 1989;30:1739–40.PubMed

29.

Bouchet LG, Bolch WE, Blanco HP, Wessels BW, Siegel JA, Rajon DA, et al. MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. J Nucl Med 2003;44:1113–47.PubMed

30.

Clerc J, Kahn E, Fragu P. SIMS evidence that carbimazole enhances spatial heterogeneity of thyroid iodine storage and targeting in a woman with Graves’ disease. Cell Mol Biol (Noisy-le-grand) 2001;47:519–27.

31.

Hindie E, Leenhardt L, Vitaux F, Colas-Linhart N, Grosclaude P, Galle P, et al. Non-medical exposure to radioiodines and thyroid cancer. Eur J Nucl Med Mol Imaging 2002;29(Suppl 2):S497–512. Review.PubMed

32.

Ashizawa K, Shibata Y, Yamashita S, Namba H, Hoshi M, Yokoyama N, et al. Prevalence of goiter and urinary iodine excretion levels in children around Chernobyl. J Clin Endocrinol Metab 1997;82:3430–3.PubMedCrossRef

33.

Gembicki M, Stozharov AN, Arinchin AN, Moschik KV, Petrenko S, Khmara IM, Baverstock KF. Iodine deficiency in Belarusian children as a possible factor stimulating the irradiation of the thyroid gland during the Chernobyl catastrophe. Environ Health Perspect 1997;105(Suppl 6):1487–90.PubMedCrossRef

34.

Shakhtarin VV, Tsyb AF, Stepanenko VF, Orlov MY, Kopecky KJ, Davis S. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 2003;32:584–91.PubMedCrossRef

35.

Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005;97:724–32.PubMedCrossRef

36.

Boltze C, Brabant G, Dralle H, Gerlach R, Roessner A, Hoang-Vu C. Radiation-induced thyroid carcinogenesis as a function of time and dietary iodine supply: an in vivo model of tumorigenesis in the rat. Endocrinology 2002;143:2584–92.PubMedCrossRef

Titel: Calculation of electron dose to target cells in a complex environment by Monte Carlo code “CELLDOSE”
verfasst von: Elif Hindié
Christophe Champion
Paolo Zanotti-Fregonara
Domenico Rubello
Nicole Colas-Linhart
Laura Ravasi
Jean-Luc Moretti
Publikationsdatum: 01.01.2009
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2009
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-008-0893-z

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques

Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction

Beyond haematuria in uro oncology: imaging biomarkers lag behind needs

Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting α3 integrin

Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT

Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP